(1 - 7 von 7
)
Actemra for systemic JIA yields 75% remission rate after 1 year
www.healio.com
“Tocilizumab is a humanized monoclonal antibody directed against the [interleukin-6 (IL-6)] receptor,” Elke Lainka, MD, of the University ...
History of Changes for Study: NCT
clinicaltrials.gov
Contact:Contact: Nicole Weyandt . Contact:Principal Investigator: Elke Lainka, MD. Hungary. Semmelweis University [Recruiting]
sortiert nach Relevanz / Datum